Analysts Offer Insights on Healthcare Companies: Insys Therapeutics (NASDAQ: INSY) and Chemed (NYSE: CHE)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Insys Therapeutics (NASDAQ: INSY) and Chemed (NYSE: CHE). Insys Therapeutics (NASDAQ: INSY) RBC Capital analyst More »

Canaccord Genuity Believes Atlassian (NASDAQ: TEAM) Still Has Room to Grow

In a report released yesterday, Richard Davis from Canaccord Genuity reiterated a Buy rating on Atlassian (NASDAQ: TEAM), with a price target of $40. The company’s shares opened today at $34.48, close More »